Outcome in Phospholamban R14del Carriers

Ingrid A.W. van Rijsingen; Paul A. van der Zwaag; Judith A. Groeneweg; Eline A. Nannenberg; Jan D.H. Jongbloed; Aeilko H. Zwinderman; Yigal M. Pinto; Ronald H. Lekanne dit Deprez; Jan G. Post; Hanno L. Tan; Rudolf A. de Boer; Richard N.W. Hauer; Imke Christiaans; Maarten P. van den Berg; J. Peter van Tintelen; Arthur A.M. Wilde

Journal ArticleOPEN ACCESS

Outcome in Phospholamban R14del Carriers

van Rijsingen I
van der Zwaag P
Groeneweg J
et al.

Circulation: Cardiovascular Genetics (2014) 7(4) 455-465

DOI: 10.1161/circgenetics.113.000374

N/ACitations

11Readers

Abstract

Background—The pathogenic phospholamban R14del mutation causes dilated and arrhythmogenic right ventricular cardiomyopathies and is associated with an increased risk of malignant ventricular arrhyt...

Cite

CITATION STYLE

APA

van Rijsingen, I. A. W., van der Zwaag, P. A., Groeneweg, J. A., Nannenberg, E. A., Jongbloed, J. D. H., Zwinderman, A. H., … Wilde, A. A. M. (2014). Outcome in Phospholamban R14del Carriers. Circulation: Cardiovascular Genetics, 7(4), 455–465. https://doi.org/10.1161/circgenetics.113.000374

Outcome in Phospholamban R14del Carriers

Abstract

Cite

Register to see more suggestions